AzTrials
AzTrials

Papillomavirus VaccinesNCT06535139

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

A study testing Brief training, Parent-targeted motivational aids and Healthcare access in people with Papillomavirus Vaccines, run by University of Florida at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

There are three main objectives of the protocol. First, we will evaluate the added clinical- and cost- effectiveness of parent-targeted motivational aids (reminder/recall and phone-based MI) alone and when combined with community-targeted healthcare access assistance beyond the effects of clinician-targeted training. Read more about this study

Who is it for?
Ages 8 to 99 years
Conditions the study is for
Papillomavirus Vaccines
What is being tested?
Brief training, Parent-targeted motivational aids and Healthcare access
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4,630 participants
Where
1 siteUnited States
Study dates
9 Dec 2024to 1 Jul 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 99 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Adolescents Age 8- to 12-years-old Visited participating clinic in past year or during study No records of receiving both HPV vaccine doses
  • Providers Provide 9- to 12-year-old patients primary care Practice at a participating clinic

Who cannot join

  • Adolescents Out of age range
  • Providers Unwilling to consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Stephanie Staras, PhD contact

352-294-8299

sstaras@ufl.edu

Marta Hansen, MBA contact

352-627-9075

m.hansen1@ufl.edu

United States1 site, 1 recruiting
  • University of Florida

    Gainesville, Florida, 32608

    Recruiting

Other trials in United States

About this study

Official title: ReMARk: A Multi-level Intervention Addressing Disparities in Rural HPV-related Cancer Prevention: Part 3- Evaluation

There are three main objectives of the protocol. First, we will evaluate the added clinical- and cost- effectiveness of parent-targeted motivational aids (reminder/recall and phone-based MI) alone and when combined with community-targeted healthcare access assistance beyond the effects of clinician-targeted training. Second, we will estimate the differential effectiveness of the implementation strategies by patient-level factors (age, race/ethnicity, sex, distance from home to clinic, social vulnerability). Third, we will measure moderation of implementation strategy effectiveness by clinic-level factors (HPV vaccination priority, resources, clinic visit types, scheduling practices, and implementation success).

Within 11 rural North Central Florida counties, we will evaluate the layering of evidence-based implementation strategies that progressively addressing clinician, parent, and healthcare access barriers faced by rural communities on HPV vaccination rates among 9- to 12-year-olds. To best address our main question of whether layering complementary strategies continues to increase effects on HPV vaccination, we will test our hypotheses with a three-arm cluster randomized study design of nested strategies. The proposed nested study design optimizes evaluation, causal inference, and scientific rigor by putting the maximum number of clinics towards addressing the layering of strategies. Randomization will occur at the clinic level. All clinics will receive implementation strategy A: clinician-targeted recommendation training. A random 20 of 30 of clinics will also receive facilitation of parent-targeted motivational aids (B) for an implementation strategy package of A+B. Finally, a random half of the clinics who receive A+B will also receive community-targeted healthcare access (C) for a total implementation strategy package of A+B+C. This equates to a three-arm cluster randomized trial in which 10 clinics receive clinician- targeted recommendation training alone (A), 10 clinics receive clinician-targeted recommendation training and parent-targeted motivational aids (A+B), and 10 clinics receive clinician-targeted recommendation training, parent-targeted motivational aids, and community-targeted healthcare access (A+B+C).

Read the detailed description

There are three main objectives of the protocol. First, we will evaluate the added clinical- and cost-effectiveness of parent-targeted motivational aids (reminder/recall and phone-based MI) alone and when combined with community-targeted healthcare access assistance beyond the effects of clinician-targeted training. Second, we will estimate the differential effectiveness of the implementation strategies by patient-level factors (age, race/ethnicity, sex, distance from home to clinic, social vulnerability). Third, we will measure moderation of implementation strategy effectiveness by clinic-level factors (HPV vaccination priority, resources, clinic visit types, scheduling practices, and implementation success).

We propose a multilevel approach, incorporating evidence-based strategies that address clinicians' recommendations, parents' hesitations, and access to healthcare is needed to reduce the HPV-related cancer disparities in rural areas. Within 11 rural North Central Florida counties, we will adapt, implement, and evaluate the layering of evidence-based implementation strategies by progressively addressing clinician, parent, and healthcare access barriers faced by rural communities on HPV vaccination rates among 9- to 12-year-olds. To increase reproducibility, we propose a conceptual framework, specified implementation strategies, randomization, adaptive and sequential implementation strategies, process and outcome measures, appropriate statistical analysis, and conservative power calculations.

To best address our main question of whether layering complementary strategies continues to increase effects on HPV vaccination, we will test our hypotheses with a three-arm cluster randomized study design of nested strategies. The proposed nested study design optimizes evaluation, causal inference, and scientific rigor by putting the maximum number of clinics towards addressing the layering of strategies. Randomization will occur at the clinic level. All clinics will receive implementation strategy A: clinician-targeted recommendation training. A random 20 of 30 of clinics will also receive facilitation of parent-targeted motivational aids (B) for an implementation strategy package of A+B. Finally, a random half of the clinics who receive A+B will also receive community-targeted healthcare access (C) for a total implementation strategy package of A+B+C. This equates to a three-arm cluster randomized trial in which 10 clinics receive clinician-targeted recommendation training alone (A), 10 clinics receive clinician-targeted recommendation training and parent-targeted motivational aids (A+B), and 10 clinics receive clinician-targeted recommendation training, parent-targeted motivational aids, and community-targeted healthcare access (A+B+C).

Random Assignment:

Clinics will be randomized into three equal arms. Ten clinics will receive clinician-targeted recommendation training alone (A). Ten clinics will receive clinician-targeted recommendation training and parent-targeted motivational aids (A+B). Ten clinics will receive clinician-targeted recommendation training, parent-targeted motivational aids, and community-targeted healthcare access (A+B+C).

Delivery of interventions:

As delivery of interventions is conducted at the clinic level and all interventions are evidence-based, these interventions will be conducted as quality improvement.

Clinician-targeted Recommendation Training. All participating clinicians and nurses at all 30 participating clinics will be offered trainings via a one-hour Zoom video conference. Structured after and intending to enhance and expand the NCI Evidence-based Program by focusing on empathy as central to the conversation and including 9- to 10-year-olds who are not eligible for Tetanus, Diphtheria, and Pertussis or Meningitis ACWY, Drs. Staras (PI), Thompson, and Bylund developed and have conducted preliminary testing of the C-LEAR (Counsel, Listen, Empathize, Answer, Recommend) training as part of our R37 (Staras PI) (Section C.2.2). C-LEAR incorporates concepts from Motivational Interviewing, facework theories, and patient-centered communication.

Parent-targeted Motivational Aids. Twenty of the 30 clinics will be offered the parent-targeted motivational aids implementation strategy which includes reminder/recall and parent-targeted phone- based MI.

Reminder/Recall. We will facilitate clinic staff sending these customized reminder/recall messages via one of three methods (postcards, text messages, or phone calls) to increase clinic adaptability to existing services and workflow. We will assist clinics in identifying 9- to 12-year-olds who have not received the HPV vaccine though the Florida state immunization registry and their EHR systems. Reminder/recall for initiation and follow-up doses will be sent at three meaningful milestones:

(1) two weeks before an adolescent's birthday, (2) two weeks prior to fall school start, and (3) within the first weeks of January.

Parent-targeted Phone-based MI. Following our previously feasible and acceptable process for phone-based MI, parents who have been sent at least two reminder/recall messages for initiation or follow-up without response (contact or clinic visit) after one month will be eligible for phone-based MI. Based on our pilot study, we anticipate MI sessions will last approximately ten minutes.

Community-targeted Healthcare Access. We will address social determinants faced by families living in rural areas in three ways: (1) linking patients to transportation assistance, (2) providing a mobile vaccination clinic, and (3) linking patients to health insurance navigators. The activities will be managed by the UF Health Cancer Center's Community Outreach and Engagement Community Navigation office as these services are consistent with their current offerings. UF Pediatrics and UF CTSI will offer mobile vaccine clinics as part of standard of care 40 times during the intervention period (4 times for each of the 10 assigned clinics). The mobile vaccination clinics will offer all adolescent vaccines (HPV, Tetanus, Diphtheria, and Pertussis, Meningitis ACWY, Influenza - in season, and COVID-19). Adolescents will receive the vaccines free of charge: billed to insurance or the Federal Vaccines for Children Program which covers vaccines for all children 18 years and under who are eligible for Medicaid or are uninsured, underinsured, or Native American or Alaskan Native. All administered vaccines will be reported to the Florida immunization registry, and, thus discoverable by clinics statewide including participating clinics.

Statistical Analysis and Design:

We will randomize 30 participating clinics to three arms (10 clinics per study arm). We will use constrained randomization to reduce imbalance among a priori determined confounders (i.e., baseline vaccination rate). The statistical team will be blinded to study arm assignments.

Clinical Effectiveness Analysis. The proposed group randomized trial consists of clustered data with patients nested within clinics. Any statistical analysis that ignores lack of independence due to nesting will be subject to inflated type-1 errors. To account for the clinic level clustering effect, intervention effects on HPV vaccine initiation will be estimated with generalized linear mixed models. We describe briefly our general strategy for specifying both the covariance and mean models for proposed analyses in Aims 1 through 3.

In this trial, cluster sampling generates exchangeable observations, and therefore compound symmetric covariance for patients nested within clinics is appropriate. Implementing the covariance model can be done for our binary outcome (HPV vaccine initiation) in PROC GLIMMIX in SAS by specifying a random intercept for clinic. In addition to efficiently accounting for non-independence, a generalized linear mixed model approach provides the flexibility to specify different link and variance functions based. Our primary specification will be a log() link and binomial variance to directly estimate the risk ratio. Should model convergence issues arise, we will estimate a logit model on the odds scale.

Being tested
Brief training, Parent-targeted motivational aids, Healthcare access

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief trainingBehavioural

    Clinicians and nurses will receive a brief training. Each training will have a one-hour didactic and interactive session and follow-up practice sessions. Trainings will focus on providers presenting the HPV vaccine as safe, best if received at 9- to 12-years of age, and prevents cancer.

  • Parent-targeted motivational aidsBehavioural

    Parents will be sent messages via text, phone, or postcard about the HPV vaccine. Parents who do not respond to messages will be offered a phone-based motivational interview session about the HPV vaccine.

  • Healthcare accessBehavioural

    Healthcare access will involve three components coordinated by UF Health Cancer Center Community Outreach and Engagement Office: transportation assistance to a participating clinic or mobile vaccination clinic, UF mobile vaccination clinic scheduling, and connection to health insurance navigators.

Study groups in NCT06535139
Study groupRoleWhat they receive
Clinician-targeted trainingExperimentalAll clinicians and nurses will be assigned to participate in a training on how to recommend or discuss the HPV vaccine.
Receives: Behavioral: Brief training
Clinician-targeted training and Parent-targeted motivational aidsExperimentalAll clinicians and nurses will be assigned to participate in a training on how to recommend or discuss the HPV vaccine. Also, clinics will send reminder/recall messages to parents about the HPV vaccine and offer phone-based motivational interviews.
Receives: Behavioral: Brief training; Behavioral: Parent-targeted motivational aids
Clinician-targeted training, Parent-targeted motivational aids, and Healthcare AccessExperimentalAll clinicians and nurses will be assigned to participate in a training on how to recommend or discuss the HPV vaccine. Also, clinics will send reminder/recall messages to parents about the HPV vaccine and offer phone-based motivational interviews. Plus, clinics will have access to healthcare access assistance.
Receives: Behavioral: Brief training; Behavioral: Parent-targeted motivational aids; Behavioral: Healthcare access

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Initiation of the HPV Vaccine

    Binary measure at the participant level of receipt of one or more does of the HPV vaccine

    Measured: 24 months

Secondary outcomes (1)
  1. Up to date for the HPV Vaccine

    Binary measure at the participant level of receipt of two or more doses of the HPV vaccine

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2024
  2. Study start9 Dec 2024
  3. Primary completion1 May 2027 (estimated)
  4. Study completion1 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
We will test our hypotheses with a three-arm cluster randomized study design of nested strategies. Randomization will occur at the clinic level. All clinics will receive implementation strategy A: clinician-targeted recommendation training. A random 20 of 30 of clinics will also receive facilitation of parent-targeted motivational aids (B) for an implementation strategy package of A+B. Finally, a random half of the clinics who receive A+B will also receive community-targeted healthcare access (C) for a total implementation strategy package of A+B+C. This equates to a three-arm cluster randomized trial in which 10 clinics receive clinician- targeted recommendation training alone (A), 10 clinics receive clinician-targeted recommendation training and parent-targeted motivational aids (A+B), and 10 clinics receive clinician-targeted recommendation training, parent-targeted motivational aids, and community-targeted healthcare access (A+B+C).
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
4,630 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06535139
Sponsor's protocol ID
IRB202301601
Other IDs
R01CA268014
Status last verified
Oct 2026
First submitted
30 Jul 2024
Last updated
8 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Due to the possibility of identifying adolescents, clinicians, or clinic staff, and the study investigator's access to the immunization data only under data sharing agreements, data will be available to users only under a data sharing agreement. Through shared data agreements, de-identified data and documentation will be available to certified researchers once the main findings from the final dataset are released. Investigators will be charged a nonrefundable fee to cover administrative handling chargers and user support. The data-sharing agreements will include a commitment to: (1) use the data only for research; (2) not attempt to identify individuals; (3) secure the data using appropriate computer technology; (4) destroying the data after analyses are completed; and (5) acknowledge the source of the data.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in